Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Inflammatory Bowel Disease (IBD) & Interleukin-1 (IL-1) / Interleukin-1 family

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Interleukin-1 (IL-1) / Interleukin-1 family and Interleukin-1 Receptor Antagonist (IL-1 Ra) / IL-1F3 levels have been shown to be elevated in intestinal inﬂammatory conditions such as Crohn’s disease and ulcerative colitis
Casini-Raggi et al. 1995 J Immunol 154(5): 2434-40
Ludwiczek et al. 2004 Clin Exp Immunol 138(2): 323-9

Although the levels of both Interleukin-1 (IL-1) and IL-1Ra have been shown to be increased in IBD, a shift in …

References (Sources)

A Sweat-based Wearable Enabling Technology for Real- time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease
Jagannath et al. 2020 Inflammatory Bowel Diseases 26: 1533–1542
Imbalance Between Interleukin-1 Agonists and Antagonists: Relationship to Severity of Inﬂammatory Bowel Disease
Ludwiczek et al. 2004 Clin Exp Immunol 138(2): 323-9
Interleukin-1 and Interleukin-1 Receptor Antagonist in Inﬂammatory Bowel Disease
Cominelli & Pizarro 1996 Aliment Pharmacol Ther (10(Suppl 2): 49-53, discussion 4. doi: 10.1046/j.13652036.1996.22164020.x
Mucosal Imbalance of IL-1 and IL-1 Receptor Antagonist in Inﬂammatory Bowel Disease. A Novel Mechanism of Chronic Intestinal Inﬂammation
Casini-Raggi et al. 1995 J Immunol 154(5): 2434-40
Mucosal Imbalance of Interleukin-1b and Interleukin-1 Receptor Antagonist in Canine Inﬂammatory Bowel Disease
Maeda et al. 2012 Vet J 194(1): 66-70
Relationship of Interleukin-1 Receptor Antagonist to Mucosal Inﬂammation in Inﬂammatory Bowel Disease
Hyams et al. 1995 J Pediatr Gastroenterol Nutr 21(4): 419-25

AI Chat

7/1/2026

Chat with our artificial intelligence: